日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Apolipoproteins E and AV mediate lipoprotein clearance by hepatic proteoglycans

载脂蛋白E和AV介导肝蛋白聚糖清除脂蛋白。

Gonzales, Jon C; Gordts, Philip L S M; Foley, Erin M; Esko, Jeffrey D

Hepatic remnant lipoprotein clearance by heparan sulfate proteoglycans and low-density lipoprotein receptors depend on dietary conditions in mice

小鼠肝脏残余脂蛋白的清除依赖于硫酸乙酰肝素蛋白聚糖和低密度脂蛋白受体,且该过程受饮食条件的影响。

Foley, Erin M; Gordts, Philip L S M; Stanford, Kristin I; Gonzales, Jon C; Lawrence, Roger; Stoddard, Nicole; Esko, Jeffrey D

Shedding of syndecan-1 from human hepatocytes alters very low density lipoprotein clearance

人肝细胞中 syndecan-1 的脱落会改变极低密度脂蛋白的清除率。

Deng, Yiping; Foley, Erin M; Gonzales, Jon C; Gordts, Philip L; Li, Yulin; Esko, Jeffrey D

Experimental evidence for therapeutic potential of taurine in the treatment of nonalcoholic fatty liver disease.

牛磺酸治疗非酒精性脂肪肝的治疗潜力的实验证据

Gentile Christopher L, Nivala Angela M, Gonzales Jon C, Pfaffenbach Kyle T, Wang Dong, Wei Yuren, Jiang Hua, Orlicky David J, Petersen Dennis R, Pagliassotti Michael J, Maclean Kenneth N

Deletion of the basement membrane heparan sulfate proteoglycan type XVIII collagen causes hypertriglyceridemia in mice and humans.

基底膜硫酸乙酰肝素蛋白聚糖 XVIII 型胶原蛋白的缺失会导致小鼠和人类出现高甘油三酯血症

Bishop Joseph R, Passos-Bueno Maria Rita, Fong Loren, Stanford Kristin I, Gonzales Jon C, Yeh Erika, Young Stephen G, Bensadoun Andre, Witztum Joseph L, Esko Jeffrey D, Moulton Karen S